Matches in Nanopublications for { ?s ?p "[Restoration of defective cell adhesion mediated via the CD62L pathway may be one mechanism of action of imatinib in BCR-ABL-positive leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Restoration of defective cell adhesion mediated via the CD62L pathway may be one mechanism of action of imatinib in BCR-ABL-positive leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP523710.RAEBmNa-WSDIC0iiGT0fROH5z8bkyXAGcF-Ku92WGx0cY130_assertion description "[Restoration of defective cell adhesion mediated via the CD62L pathway may be one mechanism of action of imatinib in BCR-ABL-positive leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523710.RAEBmNa-WSDIC0iiGT0fROH5z8bkyXAGcF-Ku92WGx0cY130_provenance.
- assertion description "[Restoration of defective cell adhesion mediated via the CD62L pathway may be one mechanism of action of imatinib in BCR-ABL-positive leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP392260.RAk-VBt-6idgU3Od8jbiAmZLaeCtTy1eBq04KCLfwuodQ130_assertion description "[Restoration of defective cell adhesion mediated via the CD62L pathway may be one mechanism of action of imatinib in BCR-ABL-positive leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392260.RAk-VBt-6idgU3Od8jbiAmZLaeCtTy1eBq04KCLfwuodQ130_provenance.
- NP689874.RAEtFdzCMeGbM0QEGhEPGBeEjR11uaru6wjOu31eRd3a4130_assertion description "[Restoration of defective cell adhesion mediated via the CD62L pathway may be one mechanism of action of imatinib in BCR-ABL-positive leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689874.RAEtFdzCMeGbM0QEGhEPGBeEjR11uaru6wjOu31eRd3a4130_provenance.
- NP392259.RA5XBlI982XogDNaP_D081-nsZL_4EqCil2G7WEzhUwT4130_assertion description "[Restoration of defective cell adhesion mediated via the CD62L pathway may be one mechanism of action of imatinib in BCR-ABL-positive leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392259.RA5XBlI982XogDNaP_D081-nsZL_4EqCil2G7WEzhUwT4130_provenance.